NMRA Stock Analysis: Buy, Sell, or Hold?
NMRA - Neumora Therapeutics, Inc. Common Stock
$1.67
0.05 (3.09%)
▲
5d:
+10.6%
30d:
-4.57%
90d:
-20.1%
BUY
HIGH Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When NMRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NMRA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: NMRA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: NMRA is currently trading at $1.67, which is considered fair relative to its 30-day fair value range of $1.47 to $1.85.
Technical Outlook: Technically, NMRA is in a strong downtrend. Immediate support is located at $1.40, while resistance sits at $1.81. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: NMRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.53 (+291.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NMRA is in a strong downtrend. Immediate support is located at $1.40, while resistance sits at $1.81. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: NMRA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.53 (+291.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.47 -
$1.85
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.1%)
- BULLISH: Trading 291.2% below Wall St target ($6.53)
Trading Range Analysis
30-Day Trading Range
$1.47 -
$1.85
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.40
Resistance Level
$1.81
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.16
Wall Street Target
$6.53
(+291.2%)
Share & Embed Analysis
Last updated: July 02, 2026 10:39 PM ET
Data refreshes hourly during market hours. Next update: 11:39 PM
Data refreshes hourly during market hours. Next update: 11:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NMRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Daljit Singh Aurora
SELL
6165 shares
2026-02-17
Joshua Pinto
SELL
5967 shares
2026-02-17
Michael Lee Milligan
SELL
1436 shares
2026-02-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 63 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1041 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 64 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |